While critics of askapatient's anecdotal reports might call the ratings biased, assuming people would rather pan than praise, plenty of drugs and drug categories receive high and mid-range scores. In fact, the average score across the board for all 100,000 ratings appearing on askapatient, which takes no drug advertising from pharmaceutical companies, is 3.0, "somewhat satisfied."
And how objective are medical journals?
An article which established Fosamax's safety after the public used/tested the rushed through drug in unwitting "clinical trials"--"Ten Years' Experience with Alendronate [Fosamax] for Osteoporosis in Postmenopausal Women" in the March 18, 2004 New England Journal of Medicine--was funded by Merck, as were 9 of its 11 authors.
In fact one author, Arthur C. Santora, MD, reported "holding equity in Merck," according to the journal, and received "several US and international patents as inventor related to the use of bisphosphonates that are assigned to Merck."
This piece first appeared on AlterNet.org
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
1
1
1
